Zevra Therapeutics CEO Neil F. McFarlane disposes of 20,000 common shares for USD 224,948
ZVRA•Zevra Therapeutics President and CEO Neil F. McFarlane sold 20,000 common shares on Oct. 12, 2026, for a weighted average price of $11.2474. He had acquired 50,000 shares through RSU vesting two days earlier and held 417,225 shares directly after the sale.
1. Share transactions
McFarlane acquired 50,000 common shares through RSU vesting on Oct. 10, 2026, then sold 20,000 shares on Oct. 12 at a weighted average price of $11.2474. His direct holdings totaled 417,225 shares following the sale.
